Patent Assignment
Reel/Frame 072794/0436
Assignment of Assignor's Interest
Recorded: 2025-11-05
Pages: 4
Assignee
SAVIENT PHARMACEUTICALS, INC.
1 TOWER CENTER BOULEVARD, EAST BRUNSWICK, NEW JERSEY, 08816
Covered Property
(1)
Methods and Kits for Predicting Infusion Reaction Risk and Antibody-Mediated Loss of Response by Monitoring Serum Uric Acid During Pegylated Uricase Therapy
Related Assignments
(3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 5, 2025
From: SAVIENT PHARMACEUTICALS, INC.
To: CREALTA PHARMACEUTICALS LLC
Reel/Frame 073465/0174 →
Change of Name
Nov 5, 2025
From: CREALTA PHARMACEUTICALS LLC
To: HORIZON PHARMA RHEUMATOLOGY LLC
Reel/Frame 073465/0241 →
Assignment of Assignor's Interest
Nov 5, 2025
From: HORIZON PHARMA RHEUMATOLOGY LLC
To: HORIZON THERAPEUTICS USA, INC.
Reel/Frame 073465/0721 →